abstract |
The present invention relates to new derivatives of 1-benzyl-3-hydroxymethylindazole in accordance with the claims in formula (I) and to pharmaceutical compositions containing them together with a pharmaceutically acceptable carrier. In addition, the present invention relates to the use of 1-benzyl-3-hydroxymethylindazole derivatives for the preparation of a pharmaceutical composition that is active in the treatment of diseases due to expression of MCP-1, CX3CR1 or p40, and to their use in a method of treating or preventing diseases caused by expression MCP-1, CX3CR1 or p40. |